Page 2 - Gambia

Role of Maiden Pharma cough syrups in Gambia kids' deaths not confirmed

Indian Health ministry sources say the Haryana-based drug maker is currently being probed for lapses in good manufacturing practices

Cough syrup deaths in the Gambia serious issue, says WHO chief scientist

Swaminathan was speaking to reporters on Thursday on the sidelines of the annual general meeting of the Developing Countries Vaccine Manufacturers Network (DCVMN) here

Cough syrup deaths in Gambia serious issue, says WHO chief scientist

Chief scientist at the World Health Organization (WHO) Dr Soumya Swaminathan on Thursday said the death of children in Gambia, potentially linked to four Indian-made cough syrups, was a serious issue. Swaminathan was speaking to reporters on the sidelines of the annual general meeting of the Developing Countries Vaccine Manufacturers Network (DCVMN) here. A WHO report has linked the death of 66 children in Gambia to four Indian-made cough syrups. "Certainly, the government is in touch with WHO as WHO actually provided the report based on the investigation which was done to prove that it was because of the diethylene glycol contamination. It is a very serious issue and it has to be taken very seriously," said Swaminathan. In India there are central as well as state-level drug regulators and there is a need to harmonize their operations, she said. "There are no mechanisms where regulators of different states can actually work together, do the inspections on each other's products," .

After the Gambia, Nigeria, Liberia issue alerts over Maiden Pharma's syrups

Nigeria has reportedly circulated the alert across all professional bodies, health care providers and supply chain associates

Several states initiate action over contaminated cough syrup controversy

According to the media reports, Karnataka has directed all drugmakers to test samples of glycerine and propylene glycol and submit a report within seven days.

Best of BS Opinion: Beyond inflation target, lessons from Maiden, and more

Here is the best of Business Standard's opinion pieces for today

Lessons from Maiden: Gambia deaths raise several questions

Pharma regulatory system needs re-examination. It's not just overseas buyers of Indian pharma products who are at potential risk. Counterfeit drugs remain a major threat in the domestic market

EAM talks to Gambian counterpart on kids' death linked to cough syrups

Dr S. Jaishankar spoke to his Gambian counterpart Dr. Mamadou Tangara and conveyed condolences on the deaths of young children allegedly linked to the contaminated cough syrups produced in India

Drug regulator halts production at Maiden Pharma's Sonipat unit

Centre forms panel to analyse causal relation between deaths and cough syrups

Govt forms panel to study WHO reports on deaths linked to 4 Indian syrups

The government on Wednesday formed a four-member panel of experts to examine the details and adverse event reports received from the WHO on the deaths of 66 children in The Gambia being linked potentially to the four made-in-India cough syrups, official sources here said. They said the committee will recommend further course of action to the Drugs Controller General of India (DCGI) after examining and analysing the adverse event reports, causal relationship and all related details already shared by or to be shared by the World Health Organization. The development comes on a day the Haryana government ordered the halting of drug manufacturing at the Sonipat unit of Maiden Pharmaceuticals while the state drug regulator has asked it to explain within a week "many contraventions" found during a recent inspection, or face suspension or cancellation of license. The order to halt production came days after the WHO potentially linked four cough syrups manufactured at the facility to the ...

Preliminary report suggests lapse in manufacturing process at Maiden Pharma

The firm has been in news for supplying contaminated cough syrups to Gambia, which is linked to the deaths of 66 children due to the presence of contaminants

Gambia police link child deaths to cough syrup imported by US firm

The deaths of 69 children from acute kidney injury in Gambia is linked to four cough syrups made in India and imported into the West African country via a US-based pharma firm, the Gambian police said

Gambia police investigate children' deaths linked to Indian cough syrup

Police in Gambia are investigating the deaths of 66 children, which have been linked to four brands of imported Indian cough syrup, the media reported

Maiden Pharma's cough syrups, under WHO scanner, not sold in India: Sources

Meanwhile, the Indian regulator is awaiting evidence of links between the cough syrups and the deaths in Gambia

Gambia urgently recalls cough syrups blamed for deaths of 66 children

Gambia has launched an urgent door-to-door campaign to remove cough and cold syrups blamed for the deaths of more than 60 children from kidney injury in the tiny West African country. Speaking to The Associated Press, the Director of Health Dr. Mustapha Bittaye confirmed the wave of child deaths from acute kidney injury, sending shockwaves across the country of 2.4 million people and around the world. The World Health Organisation has issued an alarm in response to the deaths. WHO has issued a medical product alert for four contaminated medicines identified in The Gambia that have been potentially linked to acute kidney injuries and 66 deaths among children, WHO Director-General Tedros Adhanom Ghebreyesus said in a statement issued on Wednesday. The loss of young lives is beyond heartbreaking for their families, he said. The four medicines are cough and cold syrups produced in India, said the WHO statement. While the contaminated products have so far only been detected in Gambia,

WHO issues alert for 4 India-made cough syrups; check symptoms here

WHO has asked not to use these four products until analysed by the relevant national regulatory authorities

Haryana drug firm under WHO scanner for supplying contaminated drugs

Maiden Pharma has manufactured and exported the products only to Gambia so far

Cough syrups by Indian firm potentially tied to 66 deaths in Gambia: WHO

WHO issued a medical product alert for the four syrups and said it was conducting further investigation with New Delhi-based Maiden Pharmaceuticals and regulatory authorities in India

Gambian VP arrives in India, set to participate in CII-EXIM Bank Conclave

Vice President of Gambia Badara A. Joof arrived in India on a five-day visit where he is set to participate in the Confederation of Indian Industry and EXIM Bank of India (CII-EXIM) Bank Conclave 2022 along with other bilateral engagements.In a tweet, the Ministry of External Affairs wrote, "Strengthening the partnership. Greetings to Vice President of The Gambia on his arrival in India. He is on a 5-day visit to India and will participate in CII-EXIM Bank Conclave 2022, besides having other bilateral engagements."Meanwhile, the Namibian Deputy Prime Minister and Foreign Minister Netumbo Nandi-Ndaitwah arrived in the national capital on Sunday for the CII-EXIM Bank Conclave."Warm welcome to DPM & FM Netumbo Nandi-Ndaitwah of Namibia in India. Her participation in CII-EXIM Bank Conclave and extensive engagements over the next few days will further deepen our relations with Namibia in all spheres," External Affairs Ministry spokesperson Arindam Bagchi had said in a tweet.The event

Gambia becomes latest African nation to quit ICC

The shock move announced was condemned by rights groups as a drastic blow for victims of serious crimes across the world